> top > docs > PMC:7253235 > spans > 41297-41559 > annotations

PMC:7253235 / 41297-41559 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
1394 0-14 Disease denotes Cardiotoxicity MESH:D066126
1395 34-40 Disease denotes cancer MESH:D009369
1396 59-73 Disease denotes cardiomyopathy MESH:D009202
1397 75-86 Disease denotes arrhythmias MESH:D001145
1398 92-100 Disease denotes ischemic MESH:D007511
1399 128-134 Disease denotes cancer MESH:D009369
1400 188-196 Disease denotes COVID-19 MESH:C000657245
1401 210-228 Disease denotes cardiac and cancer MESH:D006338
1402 253-262 Disease denotes mortality MESH:D003643

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T409 34-40 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T410 59-73 Disease denotes cardiomyopathy http://purl.obolibrary.org/obo/MONDO_0004994
T411 75-86 Disease denotes arrhythmias http://purl.obolibrary.org/obo/MONDO_0007263
T412 128-134 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T413 188-196 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T414 222-228 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T225 34-40 Phenotype denotes cancer http://purl.obolibrary.org/obo/HP_0002664
T226 59-73 Phenotype denotes cardiomyopathy http://purl.obolibrary.org/obo/HP_0001638
T227 75-86 Phenotype denotes arrhythmias http://purl.obolibrary.org/obo/HP_0011675
T228 128-134 Phenotype denotes cancer http://purl.obolibrary.org/obo/HP_0002664
T229 157-165 Phenotype denotes oncology http://purl.obolibrary.org/obo/HP_0002664
T230 222-228 Phenotype denotes cancer http://purl.obolibrary.org/obo/HP_0002664

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T262 0-262 Sentence denotes Cardiotoxicity experienced during cancer treatments (i.e., cardiomyopathy, arrhythmias, and ischemic events) • Further delay of cancer treatments and cardio-oncology evaluation because of COVID-19 may increase cardiac and cancer-related comorbidity and mortality